Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IMPLAC: Imaging for Unstable Carotid Atherosclerosis
NCT03333330Phase 3Completed
- Start
- Apr 2012
- Primary completion
- Oct 2017
01
Overview
Phase 3, open-label, single-arm trial. Primary endpoints: Progression of White Matter Hyperintensities at 18 months and Progression of Gray Matter/All Brain Atrophy at 18 months. Started Apr 2012; status: completed.
Beyond the preview
Go deeper on NCT03333330.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03333330.